IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.25
+2.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 79.81x
- P/S forward
- 9.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.31x
- Price / sales
- 14.29x
- Price / cash flow
- -17.57x
Enterprise value
- Enterprise value
- $4.4B
- EV / sales
- 13.51x
- EV / EBITDA
- -16.71x
- EV / EBIT
- -14.57x
- Market cap
- $4.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026